Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
AKTIENPREIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionCypress Capital, LLC
Latest Disclosed Ownership46,061 shares
Latest Disclosed Value $ 2,793,600
Cypress Capital, LLC reports 21.08% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 28, 2026 - Cypress Capital, LLC filed a 13F-HR form disclosing ownership of 46,061 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $2,414,518 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 38,042 shares of Bristol-Myers Squibb Company. This represents a change in shares of 21.08% during the quarter. The current value of the position is $2,184,673 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 46,061 8,019 21.08 2,794 36.18 0.7948
2026-02-06 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 38,042 -8,350 -18.00 2,052 -1.96 0.5745
2025-10-23 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 46,392 -1,571 -3.28 2,092 -5.77 0.5986
2025-08-07 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 47,963 -104 -0.22 2,220 -24.26 0.6448
2025-04-25 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 48,067 479 1.01 2,932 8.92 0.8451
2025-02-03 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 47,588 9,693 25.58 2,692 37.30 0.7697
2024-11-12 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 37,895 3,014 8.64 1,961 35.36 0.5058
2024-08-22 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 34,881 1,234 3.67 1,449 -20.61 0.4326
2024-10-29 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 33,647 30 0.09 1,825 5.80 0.4990
2024-02-05 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 33,617 1,124 3.46 1,725 -8.54 0.5236
2023-11-09 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 32,493 -598 -1.81 1,886 -10.92 0.5787
2023-08-07 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 33,091 837 2.60 2,116 -5.32 0.6370
2023-04-27 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 32,254 858 2.73 2,236 -1.02 0.7345
2023-02-01 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 31,396 281 0.90 2,259 -99.90 0.7459
2023-02-01 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 31,115 2,273 7.88 2,211,965 99,493.20 0.8302
2022-08-04 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 28,842 1,356 4.93 2,221 10.66 0.3230
2022-05-09 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 27,486 984 3.71 2,007 21.49 0.2519
2022-02-10 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 26,502 852 3.32 1,652 8.83 0.1949
2022-02-10 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 25,650 2,264 9.68 1,518 -2.88 0.1928
2021-08-16 2021-06-30 13F Bristol Myers Squibb Co Com COM 110122108 23,386 3,286 16.35 1,563 23.17 1.5272
2021-05-17 2021-03-31 13F Bristol Myers Squibb Co Com COM 110122108 20,100 1,570 8.47 1,269 10.44 0.5177
2021-02-16 2020-12-31 13F BRISTOL MYERS SQUIBB CO COM COM 110122108 18,530 -204 -1.09 1,149 0.52 0.5208
2020-11-12 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 18,734 -211 -1.11 1,143 2.60 0.5303
2020-08-20 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 18,945 3,183 20.19 1,114 10.08 0.4931
2020-02-10 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 15,762 1,046 7.11 1,012 35.66 0.4255
2019-11-21 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 14,716 1,274 9.48 746 22.50 0.3429
2019-07-11 2019-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 13,442 827 6.56 609 1.16 0.2752
2019-05-01 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 12,615 1,279 11.28 602 2.21 0.2509
2019-02-14 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 11,336 11,336 589 0.2709
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.